Skip to main content


Table 1 Summary of study assessments and procedures

From: Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial

  1. Performed by a physician at a medical institution
  2. Study subjects to perform at home
  3. aScreening and Day 1 may be performed on the same day
  4. bPatient diary is delivered on Day 1 and collected on Day 8 or upon withdrawal from the study
  5. cTSS, JESS, and DLQI will be administered before taking the test drug or control drug on Day 1
  6. dFor TSS, the situation in the past 3 days before the start of treatment will be investigated
  7. eThe morning oral condition will be confirmed on Day 8